TypeZero retweeted
Cellnovo acquiert une licence commerciale pour la techno de Pancréas Artificiel de @typezerotech hubs.ly/H076HW60 by @diabete_infos
TypeZero retweeted
On Tandem earnings call: Expects 1st-gen closed loop in early 2018, & second-gen w/@typezerotech by end of '18. -MH
TypeZero retweeted
Research project seeking "elimination of Type 1 diabetes" has been given the green light by @UVA. bit.ly/2hquVnu
TypeZero retweeted
This is bloody fantastic news. It is really hard for women entrepreneurs to get funding, esp in this area. Go, @cindygallop! xitter.cf/inbalorpaz/status/7989…
"The next biggest thing in tech in disrupting sex" @cindygallop just announced a $10m #sextech fund focused in female entrepreneurs #TNWNYC
Making great progress with awesome partners! businesswire.com/news/home/2…
TypeZero retweeted
Today we announced NIH-funded IDCL Trial will combine technologies from Tandem, @dexcom and @typezerotech tandemdiabetes.com/about-us/…
TypeZero retweeted
Abbott gets FDA clearance to bring FreeStyle Libre Pro CGM to US ow.ly/clvu304GFZj
TypeZero retweeted
Replying to @aaronjkowalski
@aaronjkowalski: People using cutting edge therapies still spend a considerable amount of time out of target @JDRF
Yes, LBGI, HBGI index can show variability day to day much better than HbA1c #DOCasksFDA #beyondA1c
Participating online today FDA T1D Outcomes Meeting - you can too! bit.ly/2bwiuqI
TypeZero retweeted
It's Monday which means only one week until the @US_FDA workshop on Outcomes #beyonda1c @diaTribeNews #DOCasksFDA
TypeZero retweeted
Tandem and @typezerotech announce license agreement to accelerate development of closed-loop AP system: ow.ly/a1U5302rZyy
We're very excited to be working with Tandem! xitter.cf/MollyMacT1D/status/756…
TypeZero retweeted
News about #cvilletech companies at cvilleinnovation.org/latest. @MadiDrop raises bridge funds; @typezerotech tests its artificial pancreas.
TypeZero retweeted
Snowboarder @SeanBusby & @ridingoninsulin joined with @typezerotech & The Barbara Davis Center on a clinical trial! ow.ly/10ceta
TypeZero retweeted
Artificial pancreas for diabetics to hit market cnb.cx/1pKx7ZJ @cnbc #diabetes #health #medical #treatments @typezerotech
Looking for a talented UI Engineer! Want to disrupt diabetes? Come work with us! bit.ly/1QEilMU















